Healthcare & Life Sciences

A career biotech executive and an investor talks about the importance of narrative toward better health outcomes.

Martin Kingston, Executive Chairman of Rothschild & Co. SA, discusses B4SA and the public-private compact driving economic reforms in South Africa.

Merck’s Head of Corporate Development and BD&L Sunil Patel on his almost three decades at the company and what it means to him to stay true to Merck.

China’s transition from a manufacturer of generic drugs to a powerhouse of biotech innovation is redrawing the pharmaceutical landscape. Europe in particular needs to sit up and take notice.

OneTeam Partners is delivering financial justice to third-string linemen, female players and other undervalued competitors across a growing number of professional and college sports.

In an age of divisiveness, Ron Bloom shares advice and experiences from a career building consensus.

“We’re building a world where doctors spend more time looking their patients in the eye,” says Lucy Orr-Ewing, Head of Policy at the Coalition for Health AI.

GE HealthCare’s outgoing president and CEO for China, Yihao Zhang, reflects on the components of success in the country’s increasingly competitive market.

AI will have—and is already having—a major impact on global challenges. Here’s our perspective on the implications for business across 9 key societal issues. By Jon Miller.

How are companies deploying AI to advance sustainability priorities and create social value?

Two Stanford Medicine leaders on AI’s potential, and what realizing it will require. By Courtney Chiang Dorman and Kate Larsen.

Chair of the Board and former Executive Chairman and CEO William P. Lauder talks about generational leadership at the prestige beauty empire.